To investigate whether the two chemokines are necessary for cDC1 recruitment into tumors, we treated WT mice with neutralizing antibodies against CCL5 (αCCL5) and XCL1 (αXCL1) or isotype-matched control antibodies and implanted them with Ptgs1/Ptgs2−/− BRAFV600E tumor cells. Here, CCL5 is linked to neoplasm.